The U.S Food and Drug Administration has approved a 5-year clinical trial of BCG vaccine in reversing Type 1 diabetes.
With the increase in sedentary lifestyle, many people in recent times are more prone to being diabetic than it used to be in the past. In the United States for instance, about 1.25 million people suffer from type 1 diabetes.
Just like in the case of HIV/AIDS, physicians are trying out possibilities of coming up with a cure for the dreaded yet common disease of our time.
2 days ago, there was a report that the medical world has come up with a probable viable solution for diabetes. Nevertheless there have been a lot of cynicism against the possibility of a cure for Diabetes.
During the 75th Scientific Sessions of the American Diabetes Association on September 18th, an announcement was made, saying that the FDA will test the vaccine on 150 people who are in an advanced stage of type 1 diabetes.
The Vaccine has been identified to be Bacillus Calmette-Guerin (BCG). BCG vaccine is used for Tuberculosis and bladder cancer treatment. It stimulates immune responses that can destroy cancer cells within the bladder.
The vaccine is said to have been used for over a century. According to the health organization, the vaccine has been declared safe in series of health occasions, and has been found to possess the potential to reverse the disease.
Dr. Denise Faustman, director of the Massachusetts General Hospital Immunobiology Laboratory in Boston, had this to say:
“In the phase I (preliminary) trial we demonstrated a statistically significant response to BCG, but our goal in (this trial) is to create a lasting therapeutic response.”
“We will be working again with people who have had type 1 diabetes for many years. This is not a prevention trial; instead, we are trying to create a regimen that will treat even advanced disease.”
According to the medical team embarking on this discovery journey, the BCG vaccine trial will last for 5 years. The 150 people who will be selected for the trial will from the age range of 18 – 60-years. They will then have one infusion a year for the next 4 years.
Regardless of the enthusiasm of emerging with a Type 1 diabetes cure in 5 years time, the likes of Professor Robert Sobel, Endocrinology department, Northwestern University’s Feinberg School of Medicine, is not.